How JPMorgan Chase performs in 2025 will largely depend on how economic conditions evolve. A backdrop of a firm labor market and durable credit conditions would support the bank's income growth.

Blueprint Medicines (NASDAQ:BPMC – Get Free Report) had its price target upped by equities research analysts at JPMorgan ...

Spring is upon the United States stock market yet again. During this time, a particular set of stocks, mostly concentrated in ...

First Hawaiian (NASDAQ:FHB – Get Free Report) had its target price upped by stock analysts at JPMorgan Chase & Co. from ...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to ...

JP Morgan analyst Arun Jayaram expressed views on ConocoPhillips (NYSE:COP) fourth-quarter results reported today. The analyst has an Overweight rating on the stock. The company reported revenue of ...

We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this article, we are going to take a ...

F ew investors would argue that JPMorgan Chase (NYSE: JPM) isn't a solid company. After all, there's a reason it's the U.S.'s biggest bank, boasting nearly $3.6 trillion worth of ...

With the stock trading near a record high, investors may be wondering if the rally has further room to run or if the opportunity has already passed. Let's discuss whether JPMorgan Chase stock is a ...

JP Morgan analyst Bill Peterson reiterated an Overweight rating on the shares of Enovix Corp (NASDAQ:ENVX) with a price forecast of $15.00. Enovix will release financial results for the fourth quarter ...